---
schema_version: "secwatch.filing_event.v1"
accession: "0001096906-23-000990"
form_type: "8-K"
ticker: "UTMD"
cik: "0000706698"
company_name: "UTAH MEDICAL PRODUCTS INC"
filed_at: "2023-05-08T23:59:59+00:00"
generated_at: "2026-06-15T14:45:31.520937+00:00"
event_type: "other_material"
sentiment: "negative"
materiality_score: 0.55
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# UTMD shareholders reject 2023 incentive plan; directors with low support remain

## Summary
- 2023 Employees’ and Directors’ Incentive Plan voted down: 1,168,480 for vs 1,590,668 against.
- Directors Hoyer (871,160 for, 1,926,073 withheld) and Beeson (1,277,218 for, 1,520,015 withheld) re-elected but board declined their resignations.
- Advisory say-on-pay passed with 2,719,953 for vs 72,499 against; shareholders prefer annual votes.
- Ratification of Haynie & Co. as auditor passed with 3,138,164 for.

## SEC filing metadata
- accession: 0001096906-23-000990
- form_type: 8-K
- ticker: UTMD
- cik: 0000706698
- company_name: UTAH MEDICAL PRODUCTS INC
- filed_at: 2023-05-08T23:59:59+00:00
- event_type: other_material
- sentiment: negative
- materiality_score: 0.55
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/706698/000109690623000990/0001096906-23-000990-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/706698/000109690623000990/utmd-20230505.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001096906-23-000990
- JSON: https://secwatch.observer/filing/0001096906-23-000990.json
- Plain text: https://secwatch.observer/filing/0001096906-23-000990.txt

## Key facts
- Shareholder Votes
  UTAH MEDICAL PRODUCTS INC shareholders approved Election of Directors at the 2023-05-05 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2023-05-05
  source text: Elected Ernst G. Hoyer as a director of the Company: For 871,160 Withheld 1,926,073 Broker Non Votes 371,084 Elected James H. Beeson as a director of the Company: For 1,277,218 Withheld 1,520,015 Broker Non Votes 371,084
  evidence_url: https://www.sec.gov/Archives/edgar/data/706698/000109690623000990/0001096906-23-000990-index.htm
- Shareholder Votes
  UTAH MEDICAL PRODUCTS INC shareholders approved Frequency of future advisory votes on executive compensation at the 2023-05-05 meeting.
  - Proposal: say on pay frequency
  - Outcome: passed
  - Meeting: 2023-05-05
  source text: Indicated a preference, the frequency of future advisory votes on the Company's executive compensation program: Every year: 2,412,492 Every two years: 17,765 Every three years: 167,728 Abstain: 199,248 Broker Non Votes: 371,084
  evidence_url: https://www.sec.gov/Archives/edgar/data/706698/000109690623000990/0001096906-23-000990-index.htm
- Shareholder Votes
  UTAH MEDICAL PRODUCTS INC shareholders rejected 2023 Employees’ and Directors’ Incentive Plan at the 2023-05-05 meeting.
  - Proposal: equity plan
  - Outcome: failed
  - Meeting: 2023-05-05
  source text: Did not approve the 2023 Employees’ and Directors’ Incentive Plan: For 1,168,480 Against 1,590,668 Abstentions 38,085
  evidence_url: https://www.sec.gov/Archives/edgar/data/706698/000109690623000990/0001096906-23-000990-index.htm
- Shareholder Votes
  UTAH MEDICAL PRODUCTS INC shareholders approved Ratification of Haynie & Co. as independent public accounting firm at the 2023-05-05 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2023-05-05
  source text: Ratified the selection of Haynie & Co. as the Company's independent public accounting firm for the year ended December 31, 2023: For 3,138,164 Against 27,552 Abstentions 2,601
  evidence_url: https://www.sec.gov/Archives/edgar/data/706698/000109690623000990/0001096906-23-000990-index.htm
- Shareholder Votes
  UTAH MEDICAL PRODUCTS INC shareholders approved Advisory vote on executive compensation at the 2023-05-05 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2023-05-05
  source text: Approved, on an advisory basis, the compensation paid to UTMD's named executive officers, including the Compensation Discussion and Analysis, compensation tables and narrative discussion: For 2,719,953 Against 72,499 Abstentions 4,781 Broker Non Votes 371,084
  evidence_url: https://www.sec.gov/Archives/edgar/data/706698/000109690623000990/0001096906-23-000990-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.